Skip to main content

Table 2 Treatment results of tumor

From: The combination therapy of high-intensity focused ultrasound with radiotherapy in locally advanced pancreatic carcinoma

Variable Value
Pain relief time (month) 5.6 (3.4–8.5)
Serum CA-199 continuous decline time (month) 4.3 (3.0–8.1)
Serum amylopsin and lipase post-HIFU (U/L) 115.8 (56.7–210.2)/222.2 (76.9–417.4)
RECIST(6 months after treatment)  
 PR (%) 43.7
 SD (%) 25.0
 PD (%) 31.3
The median overall survival (OS) time (month) 14 (8.0–15.5)
Incidences of adverse event (SIRC) (%) 12.5 (2/16)